Global Zonisamide Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Zonisamide Market Research Report 2024
Zonisamide is a medication used to treat the symptoms of epilepsy and Parkinson's disease.
According to Mr Accuracy reports new survey, global Zonisamide market is projected to reach US$ 718.8 million in 2029, increasing from US$ 489 million in 2022, with the CAGR of 6.2% during the period of 2024 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Zonisamide market research.
Key manufacturers engaged in the Zonisamide industry include Concordia, Eisai, Zydus Pharmaceuticals, Sun Pharma, Wockhardt, Mylan, APOTEX, Teva and Glenmark, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of Zonisamide were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Zonisamide market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Zonisamide market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Concordia
Eisai
Zydus Pharmaceuticals
Sun Pharma
Wockhardt
Mylan
APOTEX
Teva
Glenmark
Bluepharma
Invagen Pharmaceuticals
Intas Pharmaceuticals
Segment by Type
25mg
50mg
100mg
Adult
Pediatric
Geriatric
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Zonisamide report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source
According to Mr Accuracy reports new survey, global Zonisamide market is projected to reach US$ 718.8 million in 2029, increasing from US$ 489 million in 2022, with the CAGR of 6.2% during the period of 2024 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Zonisamide market research.
Key manufacturers engaged in the Zonisamide industry include Concordia, Eisai, Zydus Pharmaceuticals, Sun Pharma, Wockhardt, Mylan, APOTEX, Teva and Glenmark, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of Zonisamide were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Zonisamide market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Zonisamide market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Concordia
Eisai
Zydus Pharmaceuticals
Sun Pharma
Wockhardt
Mylan
APOTEX
Teva
Glenmark
Bluepharma
Invagen Pharmaceuticals
Intas Pharmaceuticals
Segment by Type
25mg
50mg
100mg
Segment by Application
Adult
Pediatric
Geriatric
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Zonisamide report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source